Join the club for FREE to access the whole archive and other member benefits.

Tristan Edwards

Co-Founder of Life Biosciences, Executive Chairman at Proto Axiom

Tristan Edwards is an investment professional and Co-founder, President and Chief Investment Officer of Life Biosciences. This US biotech start-up is researching potential treatments to improve human healthspan.

Tristan Edwards is Proto Axiom's Executive Chairman. Tristan has had a 25–year career, highlighted by co-founding and first CEO of Boston-based Life Biosciences, the world’s leading human longevity company, making drugs to treat causes of aging.

He previously spent 18 years global funds management experience spanning Australia, London, Hong Kong, and Singapore, trading all asset classes with a focus on Asian equities (Goldman Sachs Asset Management, Brevan Howard Asset Management, Trafalgar Capital, Mosaic Asset Management).

Visit website:


See also: Company Life Biosciences - Drug development company promoting longevity and finding treatments for age-related diseases

Tristan Edwards News

Investing in the Longevity industry

Longevity Technology - 18-Sep-2019

Edwards believes 20–30 years will be added to the average lifespan with none of the ageing diseases